Femoral Nerve Block vs Peri-capsular Nerve Group Block for Hip Fracture Analgesia
Comparison of Femoral Nerve Block Versus Peri-capsular Nerve Group Block for Analgesia During Positioning for Spinal Anesthesia in Patients With Hip Fracture
1 other identifier
interventional
52
1 country
1
Brief Summary
The purpose of the study is to compare the analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2022
CompletedFirst Posted
Study publicly available on registry
July 6, 2022
CompletedStudy Start
First participant enrolled
July 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2022
CompletedMarch 13, 2023
June 1, 2022
4 months
June 20, 2022
March 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of pain scores assessed by Numerical rating Score Scale during positioning for spinal anesthesia
Pain scores will be assessed by Numerical Rating Scale (NRS) scores (from 0=no pain to 10=maximum possible pain).
30 minutes
Secondary Outcomes (4)
Rate of pain scores at rest
30 min
Rate of pain scores on passive limb lifting
30 min
rate of postoperative pain scores
24 hours
Amount of postoperative analgesic consumption
24 hours
Study Arms (2)
Femoral nerve block group
OTHERThirty minutes before the placement of spinal block, patients will be receive a femoral nerve block with Bupivacaine.
Peri-capsular nerve group block group
OTHERThirty minutes before the placement of spinal block, patients will be receive a peri-capsular nerve group block with Bupivacaine.
Interventions
Patients will be performed a femoral nerve block using bupivacaine thirty minutes before the performing of spinal block.
Patients will be performed a peri-capsular nerve group block using bupivacaine thirty minutes before the performing of spinal block.
Eligibility Criteria
You may qualify if:
- patients with hip fracture scheduled for surgery under spinal anesthesia.
You may not qualify if:
- hemorrhagic diathesis,
- peripheral neuropathy,
- allergy to local anesthetics,
- mental disorders,
- use of analgesics for 8 h before the performance of spinal block
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antalya Training and Research Hospital
Antalya, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Safa Eroglu, M.D.
Antalya Traning and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2022
First Posted
July 6, 2022
Study Start
July 6, 2022
Primary Completion
November 7, 2022
Study Completion
December 19, 2022
Last Updated
March 13, 2023
Record last verified: 2022-06